- ORCID iD
-
0000-0002-8293-2885
Show
Sort by
-
[18F]AlF-PSMA-11 PET/CT in stage III–IV head and neck squamous cell carcinoma : interim results of the PANTHEON-18 trial
-
- Journal Article
- A1
- open access
Breast cancer Intraoperative Margin Assessment using specimen PET-CT (BIMAP)
-
- Conference Paper
- C3
- open access
Fractionated versus single-dose PSMA-targeted radioligand therapy as adjuvant therapy in a murine model for oral squamous cell carcinoma treated with immune checkpoint inhibitors
-
Non-tumour-specific PSMA-targeted radionuclide therapy enhances immune checkpoint inhibition in a syngeneic oral cancer model
-
Evaluation of [111In]FAPI-46 via dual-isotope SPECT imaging as a predictive radioligand for [177Lu]FAPI-46 biodistribution and dosimetry in mice
-
- Conference Paper
- C3
- open access
Prostate-specific membrane antigen-targeted radionuclide therapy as adjunct to Immune checkpoint Inhibition in an immunocompetent murine model for oral squamous cell carcinoma
-
Contact immunofluorescence : a novel methodology for intraoperative ex vivo margin assessment using fluorescent EGFR-targeting nanobodies
(2024) EUROPEAN JOURNAL OF SURGICAL ONCOLOGY. In European Journal of Surgical Oncology 50(Supplement 2). p.109-110 -
Prostate-specific membrane antigen-targeted radionuclide therapy as a novel therapeutic approach in a syngeneic immunocompetent murine model for oral squamous cell carcinoma
-
- Journal Article
- A1
- open access
Potential application of [18F]AlF-PSMA-11 PET/CT in radioiodine refractory thyroid carcinoma
-
Divergent fates : the ambiguous role of M2-like TAMs in oropharyngeal cancer